vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $21.2M, roughly 1.5× Autolus Therapeutics plc). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -373.3%, a 372.9% gap on every dollar of revenue. Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
AUTL vs SAMG — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $32.0M |
| Net Profit | $-79.1M | $-120.0K |
| Gross Margin | — | — |
| Operating Margin | -337.9% | -2.8% |
| Net Margin | -373.3% | -0.4% |
| Revenue YoY | — | -0.0% |
| Net Profit YoY | 3.6% | -107.4% |
| EPS (diluted) | $-0.30 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $32.0M | ||
| Q3 25 | $21.2M | $31.3M | ||
| Q2 25 | $20.9M | $30.7M | ||
| Q1 25 | $9.0M | $31.4M | ||
| Q4 24 | — | $32.0M | ||
| Q3 24 | $0 | $30.4M | ||
| Q2 24 | $0 | $31.0M | ||
| Q1 24 | $10.1M | $30.3M |
| Q4 25 | — | $-120.0K | ||
| Q3 25 | $-79.1M | $618.0K | ||
| Q2 25 | $-47.9M | $1.9M | ||
| Q1 25 | $-70.2M | $2.5M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | $-82.1M | $2.3M | ||
| Q2 24 | $-58.3M | $2.7M | ||
| Q1 24 | $-52.7M | $3.0M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | -337.9% | 4.3% | ||
| Q2 25 | -292.6% | 13.2% | ||
| Q1 25 | -726.3% | 15.4% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 14.6% | ||
| Q2 24 | — | 17.1% | ||
| Q1 24 | -384.1% | 19.5% |
| Q4 25 | — | -0.4% | ||
| Q3 25 | -373.3% | 2.0% | ||
| Q2 25 | -229.0% | 6.3% | ||
| Q1 25 | -781.1% | 7.9% | ||
| Q4 24 | — | 5.1% | ||
| Q3 24 | — | 7.4% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | -522.1% | 9.9% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | $-0.30 | $0.07 | ||
| Q2 25 | $-0.18 | $0.21 | ||
| Q1 25 | $-0.26 | $0.26 | ||
| Q4 24 | — | $0.16 | ||
| Q3 24 | $-0.31 | $0.24 | ||
| Q2 24 | $-0.22 | $0.28 | ||
| Q1 24 | $-0.24 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $50.3M |
| Total Assets | $661.9M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $44.1M | ||
| Q3 25 | $86.1M | $36.1M | ||
| Q2 25 | $123.8M | $30.0M | ||
| Q1 25 | $95.8M | $36.3M | ||
| Q4 24 | — | $68.6M | ||
| Q3 24 | $657.1M | $58.1M | ||
| Q2 24 | $705.9M | $49.9M | ||
| Q1 24 | $758.5M | $39.7M |
| Q4 25 | — | $50.3M | ||
| Q3 25 | $265.5M | $58.9M | ||
| Q2 25 | $346.5M | $64.6M | ||
| Q1 25 | $371.1M | $80.0M | ||
| Q4 24 | — | $80.7M | ||
| Q3 24 | $477.0M | $84.6M | ||
| Q2 24 | $527.8M | $85.3M | ||
| Q1 24 | $582.0M | $83.9M |
| Q4 25 | — | $166.6M | ||
| Q3 25 | $661.9M | $157.6M | ||
| Q2 25 | $721.0M | $152.7M | ||
| Q1 25 | $746.3M | $159.9M | ||
| Q4 24 | — | $194.4M | ||
| Q3 24 | $827.5M | $184.2M | ||
| Q2 24 | $853.6M | $177.6M | ||
| Q1 24 | $901.4M | $170.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $18.6M |
| Free Cash FlowOCF − Capex | $-72.3M | $15.0M |
| FCF MarginFCF / Revenue | -341.2% | 46.9% |
| Capex IntensityCapex / Revenue | 20.8% | 11.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $18.6M | ||
| Q3 25 | $-67.9M | $14.6M | ||
| Q2 25 | $-72.8M | $13.8M | ||
| Q1 25 | $-75.6M | $-24.7M | ||
| Q4 24 | — | $21.6M | ||
| Q3 24 | $-76.7M | $13.3M | ||
| Q2 24 | $-51.1M | $16.0M | ||
| Q1 24 | $-40.5M | $-24.1M |
| Q4 25 | — | $15.0M | ||
| Q3 25 | $-72.3M | $13.8M | ||
| Q2 25 | $-80.1M | $13.4M | ||
| Q1 25 | $-83.8M | $-25.1M | ||
| Q4 24 | — | $19.9M | ||
| Q3 24 | $-86.3M | $12.9M | ||
| Q2 24 | $-51.9M | $15.6M | ||
| Q1 24 | $-41.0M | $-24.7M |
| Q4 25 | — | 46.9% | ||
| Q3 25 | -341.2% | 44.1% | ||
| Q2 25 | -382.6% | 43.6% | ||
| Q1 25 | -933.1% | -80.0% | ||
| Q4 24 | — | 62.2% | ||
| Q3 24 | — | 42.4% | ||
| Q2 24 | — | 50.4% | ||
| Q1 24 | -406.8% | -81.6% |
| Q4 25 | — | 11.4% | ||
| Q3 25 | 20.8% | 2.6% | ||
| Q2 25 | 34.8% | 1.5% | ||
| Q1 25 | 91.8% | 1.3% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | 5.3% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | — | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 5.90× | ||
| Q2 24 | — | 6.00× | ||
| Q1 24 | — | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
